Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

Egypt: A recent randomized controlled trial has demonstrated that sitagliptin, a DPP-4 inhibitor, significantly improves ...

The enzyme dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (GLP-1). Since GLP-1-based therapy is a promising novel treatment of type 2 diabetes, the strategy to ...

Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of ...

New research presented at the ACG Annual Meeting suggests that GLP-1RAs lower the risk of pancreatic cancer in patients with ...

The Director of Public Prosecutions (DPP) has officially withdrawn all charges against former Mungiki leader Maina Njenga. The announcement was made by Njenga’s lawyer Ndegwa Njiru on Monday, November ...

To have enough sway to pass legislation going forward, the ruling bloc has asked for help from the Democratic Party for the People (DPP), a small centrist group. The DPP has agreed to cooperate on a ...

The DPP is trying to secure an expansion of tax allowances and a ... Japan has so far earmarked about ¥4 trillion in previous extra budgets to revive its chip sector, including ¥920 billion for ...

Japanese Prime Minister Shigeru Ishiba kept his job in a parliamentary vote on Monday, despite having led the ruling coalition to its worst general election result in 15 years.

To have enough sway to pass legislation going forward, the ruling bloc has asked for help from the Democratic Party for the ...

The Democratic Party for the People remains the third-largest opposition party in Japan, but its sharp gains in the Lower ...

The Bank of Japan should avoid overhauling its ultra-loose monetary policy now, the head of a kingmaker opposition party said ...